Literature DB >> 22955567

Nicotine differentially modulates antisaccade eye-gaze away from emotional stimuli in nonsmokers stratified by pre-task baseline performance.

Nathaniel J Wachter1, David G Gilbert.   

Abstract

RATIONALE AND
OBJECTIVE: Studies indicate that nicotine enhances some aspects of attention and executive functioning and attenuates the attentional salience of emotionally negative distractors. The purpose of this study was to assess whether nicotine can enhance executive control over prepotent responses in emotional contexts in nonsmokers and whether such enhancement is greater in individuals with low baseline performance (BP).
METHODS: The antisaccade task (AST) measures the inhibition of the tendency to glance in the direction of the onset of a visual stimulus and thus is an index of control over prepotent responses. Ten male and 14 female nonsmokers wore nicotine and placebo patches on counterbalanced days that included emotional picture primes and targets.
RESULTS: There were significant beneficial effects of nicotine on antisaccade reaction time (RT). These beneficial effects occurred in individuals with poor and average BP, but not in high baseline performers. In slow baseline RT individuals, nicotine reduced RTs associated with negative targets in the left visual field (VF) and reduced RTs associated with positive and neutral targets in the right VF. In contrast, in the average baseline group, nicotine reduced RTs for positive targets in both VFs and neutral targets in the left VF.
CONCLUSIONS: The results suggest that nicotine may produce its effects by enhancing executive functions and that the differential effects as a function of VF, target emotion, and group may also reflect lateralized differences in the effects of nicotine on brain reactivity to emotional stimuli.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955567      PMCID: PMC3547148          DOI: 10.1007/s00213-012-2842-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

Review 1.  Baseline-dependency of nicotine effects: a review.

Authors:  K A Perkins
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

2.  Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour.

Authors:  C Pierrot-Deseilligny; R M Müri; C J Ploner; B Gaymard; S Demeret; S Rivaud-Pechoux
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

3.  Dissociable effects of arousal and valence on prefrontal activity indexing emotional evaluation and subsequent memory: an event-related fMRI study.

Authors:  Florin Dolcos; Kevin S LaBar; Roberto Cabeza
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

Review 4.  Effects of nicotinic stimulation on cognitive performance.

Authors:  Paul A Newhouse; Alexandra Potter; Abhay Singh
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

5.  Emotional reactivity to emotional and smoking cues during smoking abstinence: potentiated startle and P300 suppression.

Authors:  Jeffery M Engelmann; Jonathan C Gewirtz; Bruce N Cuthbert
Journal:  Psychophysiology       Date:  2011-12       Impact factor: 4.016

6.  Emotional behavior and hemispheric side of the lesion.

Authors:  G Gainotti
Journal:  Cortex       Date:  1972-03       Impact factor: 4.027

7.  Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation.

Authors:  J H Powell; A D Pickering; L Dawkins; R West; J F Powell
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

8.  Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits.

Authors:  David Gilbert; Joseph McClernon; Norka Rabinovich; Chihiro Sugai; Louisette Plath; Greg Asgaard; Yantao Zuo; Jodi Huggenvik; Nazeih Botros
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

9.  PET studies of the influences of nicotine on neural systems in cigarette smokers.

Authors:  Jed E Rose; Frederique M Behm; Eric C Westman; Roy J Mathew; Edythe D London; Thomas C Hawk; Timothy G Turkington; R Edward Coleman
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  Nicotine improves antisaccade task performance without affecting prosaccades.

Authors:  Abigail L Larrison; Kevin A Briand; Anne B Sereno
Journal:  Hum Psychopharmacol       Date:  2004-08       Impact factor: 1.672

View more
  5 in total

1.  APOE genotype influences P3b amplitude and response to smoking abstinence in young adults.

Authors:  Ryan Coppens; Norka E Rabinovich; Raghuveer Kanneganti; Herman A Diggs; Kristin Wiggs; Travis Healey; Jodi Huggenvik; Gregory M Rose; David G Gilbert
Journal:  Psychopharmacology (Berl)       Date:  2021-01-28       Impact factor: 4.530

Review 2.  Anhedonia in Nicotine Dependence.

Authors:  David G Gilbert; Bryant M Stone
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity.

Authors:  Jonathan J Hammersley; David G Gilbert; Adam Rzetelny; Norka E Rabinovich
Journal:  Pharmacol Biochem Behav       Date:  2016-07-25       Impact factor: 3.533

4.  Increased dopamine availability magnifies nicotine effects on cognitive control: A pilot study.

Authors:  Stefan Ahrens; Joana Laux; Christina Müller; Christiane M Thiel
Journal:  J Psychopharmacol       Date:  2020-03-05       Impact factor: 4.153

5.  Cognitive performance effects of nicotine and industry affiliation: a systematic review.

Authors:  Sarah V Pasetes; Pamela M Ling; Dorie E Apollonio
Journal:  Subst Abuse       Date:  2020-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.